DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

Detalles Bibliográficos
Autores principales: Humeau, Laurent, Trimble, Cornelia, Morrow, Matthew, Shen, Xuefei, Dallas, Michael, Weiner, David, Boyer, Jean, Yan, Jian, Kraynyak, Kimberly, Sylvester, Albert, Giffear, Mary, Marcozzi-Pierce, Kathy, Shah, Divya, Broderick, Kate, Khan, Amir, Lee, Jessica, Sardesai, Niranjan, Bargarazzi, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/
http://dx.doi.org/10.1186/2051-1426-2-S3-O17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/
http://dx.doi.org/10.1186/2051-1426-2-S3-O17

Ejemplares similares